Dorsey Wright & Associates P Lx Pharma Inc. Transaction History

Dorsey Wright & Associates

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 27, 2022	SELL	$7.69 - $19.66 $36,219 - $92,598	-4,710 Closed	0 $0
Q3 2021 Oct 26, 2021	BUY	$12.22 - $21.28 $4,496 - $7,831	368 Added 8.48%	4,710 $91,000
Q1 2021 Apr 27, 2021	BUY	$5.24 - $10.14 $22,752 - $44,027	4,342 New	4,342 $39.2 Million

62.7K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.